Further analysis discovered that the positive ratio (including specimens that stained) of RPL6 was 84% (46 of 55 patients) while the positive ratio of cyclin E was 75% (41 of 55 patients) in human gastric cancer specimens. The gene discussed is RPL6; the disease is gastric cancer.